Kaiyrzhanov, R;
Rocca, C;
Suri, M;
Gulieva, S;
Zaki, MS;
Henig, NZ;
Siquier, K;
Guliyeva, U;
Mounir, SM;
Marom, D;
et al.
Kaiyrzhanov, R; Rocca, C; Suri, M; Gulieva, S; Zaki, MS; Henig, NZ; Siquier, K; Guliyeva, U; Mounir, SM; Marom, D; Allahverdiyeva, A; Megahed, H; van Bokhoven, H; Cantagrel, V; Rad, A; Pourkeramti, A; Dehghani, B; Shao, DD; Markus-Bustani, K; Sofrin-Drucker, E; Orenstein, N; Salayev, K; Arrigoni, F; Houlden, H; Maroofian, R
(2022)
Biallelic loss of EMC10 leads to mild to severe intellectual disability.
Ann Clin Transl Neurol, 9 (7).
pp. 1080-1089.
ISSN 2328-9503
https://doi.org/10.1002/acn3.51602
SGUL Authors: Maroofian, Reza
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (3MB) | Preview |
|
Microsoft Word (.docx) (Data S1)
Published Version
Available under License Creative Commons Attribution. Download (17kB) |
||
Microsoft Excel (Table S1)
Published Version
Available under License Creative Commons Attribution. Download (26kB) |
||
Microsoft Excel (Table S2)
Published Version
Available under License Creative Commons Attribution. Download (11kB) |
||
Microsoft Excel (Table S3)
Published Version
Available under License Creative Commons Attribution. Download (16kB) |
Abstract
The endoplasmic reticulum membrane protein complex subunit 10 (EMC10) is a highly conserved protein responsible for the post-translational insertion of tail-anchored membrane proteins into the endoplasmic reticulum in a defined topology. Two biallelic variants in EMC10 have previously been associated with a neurodevelopmental disorder. Utilizing exome sequencing and international data sharing we have identified 10 affected individuals from six independent families with five new biallelic loss-of-function and one previously reported recurrent EMC10 variants. This report expands the molecular and clinical spectrum of EMC10 deficiency, provides a comprehensive dysmorphological assessment and highlights an overlap between the clinical features of EMC10-and EMC1-related disease.
Item Type: | Article | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | ||||||||||||||||||||||||
Keywords: | Humans, Intellectual Disability, Membrane Proteins, Neurodevelopmental Disorders, Whole Exome Sequencing, Humans, Membrane Proteins, Intellectual Disability, Neurodevelopmental Disorders, Whole Exome Sequencing, 1103 Clinical Sciences, 1109 Neurosciences | ||||||||||||||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||||||||||||||||||||
Journal or Publication Title: | Ann Clin Transl Neurol | ||||||||||||||||||||||||
ISSN: | 2328-9503 | ||||||||||||||||||||||||
Language: | eng | ||||||||||||||||||||||||
Dates: |
|
||||||||||||||||||||||||
Publisher License: | Creative Commons: Attribution-Noncommercial 4.0 | ||||||||||||||||||||||||
Projects: |
|
||||||||||||||||||||||||
PubMed ID: | 35684946 | ||||||||||||||||||||||||
Web of Science ID: | WOS:000808306700001 | ||||||||||||||||||||||||
Go to PubMed abstract | |||||||||||||||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/114575 | ||||||||||||||||||||||||
Publisher's version: | https://doi.org/10.1002/acn3.51602 |
Statistics
Actions (login required)
Edit Item |